Advertisement
HeartCore Enterprises, Inc. saw its shares rise by nearly 10% after the company projected Q3 revenue between $19 million and $23 million, along with net profits ranging from $4 million to $8 million.
The company’s recent success has been boosted by SBC Medical Group’s IPO, which generated $17.9 million, with $17 million recognized in Q3 2024. HeartCore also holds $8 million in SBC stock after the IPO.
As of 10:54 a.m., HeartCore shares were trading 9.08% higher at $0.842, reflecting investor optimism surrounding the company’s strong growth forecast for the quarter.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.